Genomic Considerations in the Treatment of Thyroid Carcinoma

JCO Oncol Pract. 2024 Apr 15:OP2400198. doi: 10.1200/OP.24.00198. Online ahead of print.

Authors

Crystal J Hattum¹, Rachel J Elsey¹, Tobias Meissner¹, William C Spanos²

Affiliations

¹ Avera Center for Precision Oncology, Avera Cancer Institute, Sioux Falls, SD.
² Avera Medical Group Ear, Nose, and Throat-Head and Neck Surgery, Avera McKennan Hospital and University Health Center, Sioux Falls, SD.

PMID: 38621192
DOI: 10.1200/OP.24.00198

Abstract

Highlighting genomically driven targeted therapies to improve outcomes in advanced thyroid carcinoma.

Publication types

Editorial